Cookies on this site

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

Image of lungs with TB

Supported by a £10 million award from Wellcome, RESPECT-TB brings together 15 research organisations, public health bodies and national TB programmes across India, Kazakhstan, Mozambique, South Africa and Vietnam. The programme will generate evidence to improve patient care, strengthen research capacity and inform national and global TB policy.

Tuberculosis remains the world's leading infectious disease killer, causing an estimated 1.23 million deaths each year. While new six-month, bedaquiline-based regimens have transformed treatment for drug-resistant TB, increasing cure rates to around 90%, resistance to these medicines is beginning to emerge, threatening one of the biggest advances in TB care in decades.

RESPECT-TB will investigate the population level prevalence of resistance to the new drugs used to treat drug-resistant TB, as well as asking why and how this resistance develops by combining genomic sequencing, laboratory science and detailed clinical data. 

See the full story on the Nuffield Department of Medicine website.

Similar stories

From Responsive to Deep Solidarity: Reframing Global Health Governance in an Interdependent World

A new paper co-authored by Oxford Global Health Co-Director Professor Caesar Atuire and Athanasius Afful from the University of Ghana explores how the concepts of deep solidarity and responsive solidarity can help reframe global health governance and address persistent inequities.

Inside the Medicine Quality Monitoring Globe: tracking medicine quality risks in real time

A new study sets the development and the process powering the Medicine Quality Monitoring Globe, the interactive, online tool that maps real-time medicine quality reports in the media. As of October 2026, the system has captured 2.5 million articles.

International recognition at the heart of Oxford Global Health’s mission

Professor Caesar Atuire’s election as a Hastings Center Fellow brings international recognition to an approach at the heart of Oxford Global Health – connecting different perspectives, shaping research and building equitable partnerships around the world.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

New Nature Health commentary calls for solidarity in a more transactional global health era

As geopolitical interests drive a more transactional global health era, a new Nature Health commentary argues for solidarity to guide how resources are shared, decisions are made and health equity is advanced.

New Climate × Health Seminar Series connects researchers across Oxford

A new Climate × Health seminar series is bringing together researchers from across the University of Oxford to exchange ideas, showcase research and develop collaborations to address challenges at the intersection of health and climate change.

Similar stories

From Responsive to Deep Solidarity: Reframing Global Health Governance in an Interdependent World

A new paper co-authored by Oxford Global Health Co-Director Professor Caesar Atuire and Athanasius Afful from the University of Ghana explores how the concepts of deep solidarity and responsive solidarity can help reframe global health governance and address persistent inequities.

Inside the Medicine Quality Monitoring Globe: tracking medicine quality risks in real time

A new study sets the development and the process powering the Medicine Quality Monitoring Globe, the interactive, online tool that maps real-time medicine quality reports in the media. As of October 2026, the system has captured 2.5 million articles.

International recognition at the heart of Oxford Global Health’s mission

Professor Caesar Atuire’s election as a Hastings Center Fellow brings international recognition to an approach at the heart of Oxford Global Health – connecting different perspectives, shaping research and building equitable partnerships around the world.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

New Nature Health commentary calls for solidarity in a more transactional global health era

As geopolitical interests drive a more transactional global health era, a new Nature Health commentary argues for solidarity to guide how resources are shared, decisions are made and health equity is advanced.

New Climate × Health Seminar Series connects researchers across Oxford

A new Climate × Health seminar series is bringing together researchers from across the University of Oxford to exchange ideas, showcase research and develop collaborations to address challenges at the intersection of health and climate change.